Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07202273 · ClinicalTrials.gov registry record · NA
Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases
A NA study of Bone Metastases, sponsored by University of Utah.
- Recruiting
- Registry status
- NA
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT07202273: Recruiting NA study of Bone Metastases, sponsored by University of Utah.
NCT07202273 is a NA study of Bone Metastases that is actively recruiting participants, run by University of Utah. The registered enrollment target is 40 participants, below the 150-participant average among 10 other Bone Metastases trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07202273, a NA study of Bone Metastases, is actively recruiting participants, sponsored by University of Utah.
- RECRUITING
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to provide proof that patients can be treated with simulation-free, single-fraction palliative radiation therapy with a single in-person visit.
Primary Outcome
To provide proof-of-concept that patients can be treated with simulation-free, single-fraction palliative radiation therapy with only a single in-person visit to Huntsman Cancer Hospital (HCH). This will be defined as receiving simulation-free, single-fraction radiation therapy with documented real-time approval by the radiation oncologist, medical physicist, and radiation therapist that the treatment adequately covers the target without unreasonable or unsafe differences.
Conditions Studied
Interventions
- RADIATION simulation-free, single-fraction palliative radiation therapy
Study Locations (1)
Utah
- Huntsman Cancer Institute/University of Utah - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-11-03 |
| Est. Completion | 2028-10 |
| Phase | NA |
What NCT07202273 shows while recruiting
NCT07202273 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 150-participant average among 10 other Bone Metastases trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Bone Metastases appearing as the primary indexed condition, and to 1 intervention - of which simulation-free, single-fraction palliative radiation therapy is the first listed.
NCT07202273 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT07202273 about?
NCT07202273 is a clinical study titled "Simulation-Free, Single-Fraction Palliative Radiation Therapy for Treatment of Bone Metastases". The goal of this study is to provide proof that patients can be treated with simulation-free, single-fraction palliative radiation therapy with a single in-person visit.
What is the current status of trial NCT07202273?
This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-11-03. Estimated completion is 2028-10.
What conditions does trial NCT07202273 study?
This clinical trial studies the following conditions: Bone Metastases.
What interventions are being tested in trial NCT07202273?
The interventions under investigation include: simulation-free, single-fraction palliative radiation therapy (RADIATION).
Who is sponsoring clinical trial NCT07202273?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07202273 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bone Metastases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07202273's enrollment target sits among peer trials
40 8th of 10 higher than 3 of 10 other Bone Metastases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bone Metastases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Copper Cu 64-DOTA-Trastuzumab PET in Predicting Response to Treatment With Ado-Trastuzumab Emtansine in Patients With Metastatic HER2 Positive Breast Cancer
ACTIVE NOT RECRUITING · NA
-
Abductor Reattachment Methods in Proximal Femur Replacements: What is the Best Method?
RECRUITING
-
Registry for Bone Metastases
RECRUITING
-
Post-Op Pain Control for Prophylactic Intramedullary Nailing.
RECRUITING · Phase 3
-
A Phase III Randomized Trial Comparing Stereotactic Body Radiation Therapy (SBRT) vs Conventional Palliative Radiation Therapy for Painful Bone Metastases
RECRUITING · Phase 3
-
FDG PET/CT in Breast Cancer Bone Mets
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI